Trial intelligence / Profile preview

Comparison of Temporomandibular Joint Arthroscopy With Botulinum Toxin Injection Versus Placebo

NCT04810429Phase 4Completed

Sponsor
Instituto Português da Face
Start
Jan 2021
Primary completion
Dec 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in temporomandibular joint disorder (TMJ), sponsored by Instituto Português da Face. Started Jan 2021; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

temporomandibular joint disorder (TMJ)

Beyond the preview

Go deeper on NCT04810429.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04810429.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call